Back
Travere Therapeutics, Inc. Stock Predictions
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
49
TVTX
Travere Therapeutics, Inc.
Last Price:
$30.0200
Seasonality Move:
5.45%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis NowTravere Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1325.8% based on the past 19 years of stock performance.
-
Travere Therapeutics, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
-
Is Travere Therapeutics, Inc. Stock Undervalued?The current Travere Therapeutics, Inc. [TVTX] share price is $29.9400. The Score for TVTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
TVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Travere Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1325.8% based on the past 19 years of stock performance.
Travere Therapeutics, Inc. Stock Rating
Sell
49
Travere Therapeutics, Inc. (TVTX)
is a Sell
Is Travere Therapeutics, Inc. overpriced?
-
Travere Therapeutics, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
Travere Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
travere.com
52-Week Data
52-Week High:
42.1300
52-Week Low:
12.9100
Prediction Charts
Market Cap:
2.7B
Price in USD:
29.9400
Volume:
1.1M
Beta:
52.6374
Technical Analysis
SMA50:
34.5130
SMA100:
30.6605
SMA200:
23.6463
52-Wk Change:
47.42%
Stock Predictions
-
Is Travere Therapeutics, Inc. stock public?Yes, Travere Therapeutics, Inc. is a publicly traded company.
-
What is the Travere Therapeutics, Inc. stock quote today?The Travere Therapeutics, Inc. stock price is 29.9400 USD today.
-
How to buy Travere Therapeutics, Inc. stock online?You can buy Travere Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-6 | 37.7500 | 35.8000 | 38.2350 | 34.5000 |
| Jan-7 | 35.8000 | 36.2800 | 37.4500 | 35.5200 |
| Jan-8 | 35.9000 | 35.6000 | 36.5850 | 35.3300 |
| Jan-9 | 35.4400 | 34.5800 | 36.0700 | 33.9200 |
| Jan-12 | 34.2650 | 34.1000 | 34.5620 | 32.2500 |
| Jan-13 | 23.0095 | 29.1100 | 30.0000 | 22.5900 |
| Jan-14 | 29.0500 | 28.9300 | 29.1791 | 27.3600 |
| Jan-15 | 28.6700 | 28.4000 | 28.9600 | 27.7000 |
| Jan-16 | 28.5000 | 27.8700 | 29.3099 | 27.7750 |
| Jan-20 | 27.0700 | 27.9400 | 28.1710 | 26.8900 |
| Jan-21 | 27.5500 | 28.2500 | 28.2900 | 26.7801 |
| Jan-22 | 28.2000 | 29.7300 | 29.7700 | 28.0000 |
| Jan-23 | 29.6600 | 29.4400 | 30.1624 | 29.0700 |
| Jan-26 | 29.2000 | 29.9400 | 29.9700 | 29.0001 |
Travere Therapeutics, Inc. Earnings
Travere Therapeutics, Inc. Earnings Report: Per Share Travere Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Travere Therapeutics, Inc. Forecast Revenue Growth
Travere Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Travere Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $1.51 per share.
* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.